The University of Chicago Header Logo

Connection

Ezra Cohen to Oncolytic Virotherapy

Back to Details
This is a "connection" page, showing publications Ezra Cohen has written about Oncolytic Virotherapy.
Ezra Cohen
Connection Strength
0.179
Oncolytic Virotherapy
  1. Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study. Clin Cancer Res. 2020 10 01; 26(19):5153-5161.
    View in: PubMed
    Score: 0.179
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.